Abstract
RIPK1 loss enhances immunotherapy by reshaping immune populations and poising tumor cells for killing.
©2022 American Association for Cancer Research.
MeSH terms
-
Apoptosis*
-
Humans
-
Immunotherapy
-
Receptor-Interacting Protein Serine-Threonine Kinases* / genetics
-
Receptor-Interacting Protein Serine-Threonine Kinases* / metabolism
-
Tumor Necrosis Factor-alpha / metabolism
Substances
-
Tumor Necrosis Factor-alpha
-
RIPK1 protein, human
-
Receptor-Interacting Protein Serine-Threonine Kinases